An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder - REED

Study identifier:VD-NS-1101

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR

Medical condition

Bipolar Disorder

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

16000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Nov 2011
Primary Completion Date: 01 Apr 2012
Study Completion Date: 01 Apr 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria